Central - Tenders Closing By Day
States - Tenders Closing By Day

Closing Today
Closing within 7 days
Closing within 14 days
By Closing Date
Tender Calendar

Central - Tenders Closing for a specific Date

Report For Day : 05-Jun-2026

Total Tenders : 2471
Sl.No e-Published Date Bid Submission Closing Date Tender Opening Date Title/Ref.No./Tender Id State Name Corrigendum
671. 21-May-2026 11:38 AM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM L-methyl Folate 2.8 + Pyridoxal-5 Phosphate 25mg + Mecobalamine 2mg tab/82262279/107062861 Ministry of Railways --
672. 25-May-2026 01:19 PM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM audio card part no- 2023-AAC-06/10266549A/107067182 Ministry of Railways --
673. 23-May-2026 04:25 PM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM Mannitol 20 percent Infusion 100 ml bottle/80261134A/107066229 Ministry of Railways --
674. 23-May-2026 04:26 PM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM Tobramycin 0.3percent plus Dexamethasone 0.1percent Eye Drops/80261139A/107066233 Ministry of Railways --
675. 23-May-2026 04:24 PM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM Intravenous Amino Acid 200ml Infusion/80261014B/107066227 Ministry of Railways --
676. 23-May-2026 05:05 PM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM Lignocaine Hydrochloride 2 Percent Jelly tube Sterile Pack/80261015B/107066258 Ministry of Railways --
677. 23-May-2026 04:22 PM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM Methyl Prednisolone Acetate 40mg Inj/80261102A/107066222 Ministry of Railways --
678. 23-May-2026 04:23 PM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM Eye Drop contains - Moxifloxacin 0.5 Percent w/v with Dexamethasone 0.1 Percent w/v packing 5 ml phial/80261091A/107066224 Ministry of Railways --
679. 23-May-2026 04:28 PM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM Olmesartan 40mg and Hydrochlorthiazide 12.5mg Tab/80261073A/107066220 Ministry of Railways --
680. 23-May-2026 05:04 PM 05-Jun-2026 11:30 AM 05-Jun-2026 11:30 AM Each 5 ml Contains - Levosalbutamol 1 mg Pack upto 100 ml bottle/80261028C/107066261 Ministry of Railways --

Note : For more details and clarifications, please refer to the respective Portal.